METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 1,380.00
+52.00 (3.92%)
Last updated: Jun 10, 2026, 2:37 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 23.34 billion as of June 10, 2026. Its market cap has decreased by -56.67% in one year.
Market Cap
23.34B
Enterprise Value
74.76B
Revenue
36.95B
Ranking
n/a
PE Ratio
98.55
Stock Price
1,380.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 23.34B, a decrease of -41.37%. That is a compound annual growth rate of -3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 22.81B | -56.46% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.99T |
| Celltrion | 36.82T |
| ALTEOGEN | 17.49T |
| Samsung Epis Holdings | 10.48T |
| BCWORLD PHARM. | 36.96B |
| Tdspharm | 35.83B |
| Aprogen Biologics | 33.59B |
| LAMEDITECH | 26.76B |